Proton Therapy for Mediastinal Lymphoma (PROMLY)
This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.
About the trial
The study aims to investigate whether proton therapy is feasible in a national setting and whether proton therapy can reduce the risk of late toxicity (secondary cancers and heart toxicity) compared to foton therapy.
Original English text from ClinicalTrials.gov
Who can (and can't) join
✓ Qualifies
- •Wiek co najmniej 18 lat
- •Potwierdzona histologicznie choroba Hodgkina lub chłoniak nieziarniczy
- •Nowotwór ograniczony do śródpiersia, ewentualnie z zajęciem szyi i/lub pachy
- •Kwalifikacja do leczenia celującego w wyleczenie
- •Podpisana świadoma zgoda na udział w badaniu
✗ Disqualifies
- •Wcześniejsza radioterapia klatki piersiowej
- •Obecny inne nowotwór
- •Niemożliwość ukończenia pełnego kursu radioterapii lub regularnych wizyt kontrolnych
Simplified criteria — AI translation
Trial details
- Minimum age
- 18 Years
- Last updated (source)
- September 14, 2026
- Sex
- No restrictions
Therapies / drugs in trial
Locations (1)
Dept. of oncology
Copenhagen, Denmark
Trial contact
Mogens Bernsdorf, Md. Phd
Contact information from ClinicalTrials.gov. Contact in English.
Share this trial
Data from ClinicalTrials.gov. AI-assisted translation, last sync: 9/15/2026.
You can help another person
We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.